CD8A and COVID-19: Additionally, the alveoli are damaged by reactive oxygen species (ROS) because of a pro-oxidant response.[32] As stated by Wang et al,[33] there are immunological differences between moderate and severe COVID-19 patients, with the authors demonstrating that the number of CD8 + and CD4 + T cells decrease significantly in severe COVID-19 patients.